[{"address1": "1210-1220 Washington St.", "address2": "Suite 210", "city": "Newton", "state": "MA", "zip": "02465", "country": "United States", "phone": "617 344 4190", "website": "https://acumenpharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Newton, Massachusetts.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel J. O'Connell M.B.A.", "age": 55, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1047590, "exercisedValue": 0, "unexercisedValue": 1034567}, {"maxAge": 1, "name": "Dr. James  Doherty Ph.D.", "age": 57, "title": "President & Chief Development Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 730785, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matt  Zuga", "title": "CFO & Chief Business Officer", "fiscalYear": 2024, "totalPay": 703157, "exercisedValue": 0, "unexercisedValue": 254161}, {"maxAge": 1, "name": "Dr. Grant A. Krafft Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "totalPay": 42000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Caleb E. Finch Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William L. Klein Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Russell  Barton M.S.", "age": 67, "title": "Chief Operating Officer", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 223680, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  Carranza", "title": "Vice President, Finance & Accounting and Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alex  Braun M.B.A.", "title": "VP & Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Derek M. Meisner Esq., J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 752945, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.25, "open": 2.3, "dayLow": 2.27, "dayHigh": 2.47, "regularMarketPreviousClose": 2.25, "regularMarketOpen": 2.3, "regularMarketDayLow": 2.27, "regularMarketDayHigh": 2.47, "payoutRatio": 0.0, "beta": 0.245, "forwardPE": -1.2397399, "volume": 503667, "regularMarketVolume": 503667, "averageVolume": 563738, "averageVolume10days": 2466130, "averageDailyVolume10Day": 2466130, "bid": 2.37, "ask": 2.45, "bidSize": 2, "askSize": 1, "marketCap": 145376224, "fiftyTwoWeekLow": 0.855, "fiftyTwoWeekHigh": 3.05, "allTimeHigh": 26.98, "allTimeLow": 0.855, "fiftyDayAverage": 2.0639, "twoHundredDayAverage": 1.594265, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 49603220, "profitMargins": 0.0, "floatShares": 35161056, "sharesOutstanding": 60573425, "sharesShort": 599667, "sharesShortPriorMonth": 568193, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0099, "heldPercentInsiders": 0.07323, "heldPercentInstitutions": 0.64766, "shortRatio": 2.92, "shortPercentOfFloat": 0.013300001, "impliedSharesOutstanding": 60573425, "bookValue": 1.538, "priceToBook": 1.5604682, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -133351000, "trailingEps": -2.21, "forwardEps": -1.93589, "enterpriseToEbitda": -0.359, "52WeekChange": 0.61870503, "SandP52WeekChange": 0.120657206, "quoteType": "EQUITY", "currentPrice": 2.4, "targetHighPrice": 10.0, "targetLowPrice": 4.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 126609000, "totalCashPerShare": 2.09, "ebitda": -138170000, "totalDebt": 30836000, "quickRatio": 5.799, "currentRatio": 6.019, "debtToEquity": 33.095, "returnOnAssets": -0.42226002, "returnOnEquity": -0.85929, "grossProfits": -118928000, "freeCashflow": -78959504, "operatingCashflow": -123657000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ABOS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 6.66667, "regularMarketPrice": 2.4, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1625146200000, "postMarketChangePercent": -0.41666624, "postMarketPrice": 2.39, "postMarketChange": -0.00999999, "regularMarketChange": 0.15, "regularMarketDayRange": "2.27 - 2.47", "shortName": "Acumen Pharmaceuticals, Inc.", "longName": "Acumen Pharmaceuticals, Inc.", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1770423232, "regularMarketTime": 1770411603, "exchange": "NMS", "messageBoardId": "finmb_8539521", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 563738, "fiftyTwoWeekLowChange": 1.5450001, "fiftyTwoWeekLowChangePercent": 1.8070176, "fiftyTwoWeekRange": "0.855 - 3.05", "fiftyTwoWeekHighChange": -0.64999986, "fiftyTwoWeekHighChangePercent": -0.21311471, "fiftyTwoWeekChangePercent": 61.870502, "earningsTimestamp": 1762954200, "earningsTimestampStart": 1762954200, "earningsTimestampEnd": 1762954200, "earningsCallTimestampStart": 1762952400, "earningsCallTimestampEnd": 1762952400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.21, "epsForward": -1.93589, "epsCurrentYear": -2.28474, "priceEpsCurrentYear": -1.0504478, "fiftyDayAverageChange": 0.3361001, "fiftyDayAverageChangePercent": 0.16284709, "twoHundredDayAverageChange": 0.8057351, "twoHundredDayAverageChangePercent": 0.50539595, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-01", "averageAnalystRating": "1.0 - Strong Buy", "displayName": "Acumen Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]